{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NTI.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","market":"AU","secType":"STK","nameCN":"NEUROTECH INTERNATIONAL LTD","latestPrice":0.027,"timestamp":1744870320000,"preClose":0.03,"halted":0,"volume":856013,"delay":0,"nameEN":"NEUROTECH INTERNATIONAL LTD","floatShares":760583617,"shares":1042121921,"eps":-0.011964,"marketStatus":"Not Yet Opened","change":-0.003,"latestTime":"04-17 16:12:00 AEST","open":0.03,"high":0.03,"low":0.027,"amount":23933,"amplitude":0.1,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.011964,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.03,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":2.1236496046998132,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","floatShares":760583617,"roa":"-129.79%","roe":"-223.80%","lyrEps":-0.005558,"volumeRatio":2.1236496046998132,"shares":1042121921,"dividePrice":0,"high":0.03,"amplitude":0.1,"preClose":0.03,"low":0.027,"week52Low":0.026,"pbRate":"4.90","psRate":"349.64","week52High":0.1,"institutionHeld":0,"latestPrice":0.027,"eps":-0.011964,"divideRate":0,"volume":856013,"delay":0,"ttmEps":-0.011964,"open":0.03,"prevYearClose":0.055,"prevWeekClose":0.027,"prevMonthClose":0.033,"prevQuarterClose":0.033,"fiveDayClose":0.03,"twentyDayClose":0.036,"sixtyDayClose":0.048},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NTI.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTI.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523952287","title":"BUZZ-Australia's Neurotech gains as Rett Syndrome drug gets 'orphan' tag from EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2523952287","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523952287?lang=en_us&edition=fundamental","pubTime":"2025-03-31 12:35","pubTimestamp":1743395723,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Neurotech gains as Rett Syndrome drug gets 'orphan' tag from EU   ** Shares of Neurotech International NTI.AX rise 6.5% to A$0.033** Stock set for strongest session since March 18, if current gains hold** European Commission gives \"orphan drug\" designation to biopharmaceutical firm's NTI64 drug aimed at treating Rett Syndrome, a neurodevelopmental disorder that affects motor and communication skills** European Commission grants \"orphan drug\" designation to promote medicine development for rare diseases affecting no more than 5 in 10,000 people in the European Union** Co says \"orphan\" status gives it a range of incentives including 10-year market exclusivity, reduced regulatory fees and access to EU research funding** Stock down 40% YTD, including current session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL6N3QE07B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2523956755","title":"Neurotech's Drug Candidate Receives Orphan Drug Status from European Commission; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523956755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523956755?lang=en_us&edition=fundamental","pubTime":"2025-03-31 11:27","pubTimestamp":1743391639,"startTime":"0","endTime":"0","summary":"Neurotech International  has received Orphan Drug Designation from the European Commission for NTI164, its lead drug candidate for Rett Syndrome, a neurodevelopmental disorder, according to a Monday filing with the Australian bourse.The designation grants market exclusivity, reduced regulatory fees, access to research funding, and protocol assistance, the filing said.Shares of the firm rose past 3% in recent Monday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2523378029","title":"Neurotech International Says European Commission Grants NTI164 Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2523378029","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523378029?lang=en_us&edition=fundamental","pubTime":"2025-03-31 09:51","pubTimestamp":1743385917,"startTime":"0","endTime":"0","summary":"March 31 (Reuters) - Neurotech International Ltd ::*EUROPEAN COMMISSION GRANTS NTI164 ORPHAN DRUG DESIGNATION FOR RETT SYNDROME  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 30-MAR-202522:39:26.03 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nRSD3rRfpg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"gpt_icon":0},{"id":"2523180982","title":"Neurotech International -  European Commission Grants Nti164 Orphan Drug Designation for Rett Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2523180982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523180982?lang=en_us&edition=fundamental","pubTime":"2025-03-31 06:40","pubTimestamp":1743374453,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250330:nFWN3QC00I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","NTI.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTI.AU\",params:#limit:5,,,undefined,":[{"date":"2023-10-27","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698361200000,"name":null,"time":"","dateTimestamp":1698325200000,"actualEps":null},{"date":"2023-07-26","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690329600000,"name":null,"time":"","dateTimestamp":1690293600000,"actualEps":null},{"market":"AU","date":"2023-04-27","symbol":"NTI.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682517600000,"reportTimeType":"","actualEps":null},{"date":"2023-01-30","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1675033200000,"name":null,"time":"","dateTimestamp":1674997200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTI.AU\",market:\"AU\",,,undefined,":[]}}